Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer …
Over the last 12 months, insiders at Cardinal Health, Inc. have bought $0 and sold $25.97M worth of Cardinal Health, Inc. stock.
On average, over the past 5 years, insiders at Cardinal Health, Inc. have bought $29,239 and sold $11.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $14,944 was made by Brennan Michelle (director) on 2022‑11‑15.
2024-11-14 | Sale | Chief Accounting Officer | 3,504 0.0015% | $123.55 | $432,919 | -0.88% | ||
2024-08-21 | Sale | Chief Legal/Compliance Officer | 16,573 0.0068% | $109.39 | $1.81M | +2.12% | ||
2024-08-19 | Sale | Chief Executive Officer | 46,455 0.0189% | $109.02 | $5.06M | +1.99% | ||
2024-08-19 | Sale | CEO, GMPD Segment | 46,998 0.0192% | $109.21 | $5.13M | +1.99% | ||
2024-08-19 | Sale | Chief Financial Officer | 2,323 0.0009% | $108.91 | $252,998 | +1.99% | ||
2024-08-19 | Sale | Chief Human Resources Officer | 34,647 0.0141% | $109.00 | $3.78M | +1.99% | ||
2024-08-19 | Sale | Chief Information Officer | 4,000 0.0016% | $108.85 | $435,400 | +1.99% | ||
2024-08-16 | Sale | Chief Executive Officer | 26,716 0.0119% | $108.87 | $2.91M | 0.00% | ||
2024-08-16 | Sale | Chief Human Resources Officer | 3,294 0.0015% | $108.00 | $355,752 | 0.00% | ||
2024-08-15 | Sale | Chief Legal/Compliance Officer | 17,896 0.0078% | $106.48 | $1.91M | 0.00% | ||
2023-11-27 | Sale | CEO, Pharmaceutical Segment | 36,642 0.0148% | $106.31 | $3.9M | -0.61% | ||
2023-08-28 | Sale | CEO, Pharmaceutical Segment | 6,712 0.0027% | $89.81 | $602,805 | +14.72% | ||
2023-08-18 | Sale | Chief Accounting Officer | 20,695 0.0082% | $86.27 | $1.79M | +19.33% | ||
2023-08-17 | Sale | Chief Legal/Compliance Officer | 10,668 0.0043% | $87.68 | $935,370 | +18.49% | ||
2023-08-17 | Sale | CEO, Medical Segment | 37,500 0.0149% | $87.32 | $3.27M | +18.49% | ||
2023-08-17 | Sale | Chief Human Resources Officer | 26,324 0.0105% | $87.41 | $2.3M | +18.49% | ||
2023-08-17 | Sale | Chief Information Officer | 2,000 0.0008% | $86.79 | $173,580 | +18.49% | ||
2023-08-16 | Sale | Chief Legal/Compliance Officer | 30,145 0.0119% | $90.84 | $2.74M | +13.13% | ||
2022-11-15 | director | 200 <0.0001% | $74.72 | $14,944 | +15.15% | |||
2022-11-14 | director | 200 <0.0001% | $76.30 | $15,260 | +13.61% |
Snow Ola M | Chief Human Resources Officer | 27516 0.0114% | $123.28 | 2 | 5 | |
WALTER ROBERT D | director | 937754 0.3875% | $123.28 | 1 | 12 | +9.1% |
CLARK R KERRY | Former Chairman and CEO | 172680 0.0714% | $123.28 | 1 | 0 | <0.0001% |
FORD BRENDAN A | EVP-Corporate Development | 87052 0.036% | $123.28 | 1 | 4 | +25.18% |
FOTIADES GEORGE L | President & COO | 80400 0.0332% | $123.28 | 6 | 2 | <0.0001% |
The Vanguard Group | $3.43B | 12.57 | 30.62M | -2.06% | -$72.26M | 0.06 | |
BlackRock | $3.06B | 11.22 | 27.34M | +4.76% | +$139.05M | 0.07 | |
State Street | $1.59B | 5.79 | 14.11M | -2.75% | -$44.84M | 0.07 | |
Fidelity Investments | $648.59M | 2.38 | 5.8M | +7.13% | +$43.15M | 0.04 | |
Geode Capital Management | $622.18M | 2.29 | 5.57M | +2.37% | +$14.43M | 0.05 |